A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
8/21/2026
BreakingCataractChinaFLACSGlaucomaLaserPresbyopiaRefractiveRetinaRevenueSurgical
Q2-2026 Ophthalmic Revenue Roundup for STAAR, Lensar, Iridex, and Lenz
STAAR Surgical, of Lake Forest, California, reported Aug. 12 that its Q2-2026 net sales were $93.5 million, a 111 percent increase over $44.3 million in Q2-2025. China sales in Q2-2026 were $52.3 m...
8/21/2026
BreakingDealsEuropePresbyopia
Lupin’s Visufarma Licenses Yuvezzi Presbyopia Drops for Europe, UK
Visufarma, a subsidiary of India-based Lupin Limited, announced Aug. 20 that it had licensed exclusive rights to the presbyopia drop Yuvezzi in the European Union, the UK, Switzerland, Norway, and ...
8/21/2026
BreakingDeviceDry EyeRegulation
TearCare Label Expanded to Include Improvement of Meibomian Gland Function
Sight Sciences reported Aug. 19 that the US FDA had expanded the labeling for the TearCare thermal expression device to include improvement of meibomian gland function in adult patients with evapor...
8/20/2026
MeetingNewsletterRetinaSurgical
ASRS Meeting Shines Light on Ingenuity of Retina Surgeons Around the Globe
The 2026 annual meeting of the American Society of Retina Specialists (ASRS), held in mid-July at the Palais des Congrès in Montreal, Quebec, opened with a deep dive into surgery. The first day off...
8/21/2026
BiosimilarsBreakingDiagnosticIOLPharmaRetinaRevenueSurgical
Quarterly Revenue Roundup for Carl Zeiss Meditec and Santen
German company Carl Zeiss Meditec reported Aug. 6 that its ophthalmic device revenue for the three months ended June 2026 (the third quarter of its fiscal 2025/2026 year) was €437.6 million ($499.7...
8/21/2026
BreakingClinical TrialRetina
EyePoint’s Duravyu Misses Primary Visual Acuity Endpoint in Phase III Wet AMD Trial
EyePoint Pharmaceuticals reported Aug. 17 that Duravyu (vorolanib intravitreal insert) missed its primary visual acuity endpoint in topline results from the Phase III LUGANO trial in wet age-relate...
8/21/2026
BreakingDiagnosticDigital
Zeiss Gains US FDA 510(k) Clearance for Clinic 360 Data Management Software
Carl Zeiss Meditec announced Aug. 19 that it had gained 510(k) clearance from the US FDA for its Clinic 360 image and data management software. The clinical analytics dashboard combines diagnostic ...
8/21/2026
BreakingCell TherapyStudy
Researchers Aim to Conquer Jet Lag Using Engineered RPE Cells
Researchers at Rice and Northwestern universities have developed a subcutaneous therapy using engineered retinal pigment epithelial (RPE) cells that they say could help the body adapt more quickly ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.